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EuroBioForum brings people and parties together, initi-
ating annual conferences and developing a strong com-
munity leading to networking and partnering. We aim
to assure the position of Europe as the research and
implementation capital of Personalised Medicine, all for
the benefit of the patient.
Our target groups for partnerships are
national governments, bioclusters, regional initiatives,
funding organisations, national research councils, patient
organisations, scientific associations, industrial federa-
tions and the European Commission.
Personalised Medicine needs involvement of all
stakeholders
How can we address the challenges to find solutions?
The complexity of diseases and the biology of humans
are calling for a different approach. But the question is
whether the current focus of Personalised Medicine is
the solution. What are current perspectives in policy
making and funding of Personalised Medicine? How can
the aforementioned issues be addressed? How to tackle
the future challenges in Personalised Medicine?
EuroBioForum tries to provide insight into current
initiatives and key players in Personalised Medicine in Eur-
ope. From this starting point, strategic alliances and part-
nerships will be facilitated to empower the field, to warrant
scientific, economic and societal success and to capitalise
on European added value. To do so, EuroBioForum aims
to align the priorities of both funding and research
programmes at national and regional level, in order to get
the most out of every euro and out of everyone’s effort.
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